David Humphrey

2022

In 2022, David Humphrey earned a total compensation of $780.6K as Chief Financial Officer at Ensysce Biosciences, a 175% increase compared to previous year.

Compensation breakdown

Option Awards$438,562
Salary$328,333
Other$13,722
Total$780,617

Humphrey received $438.6K in option awards, accounting for 56% of the total pay in 2022.

Humphrey also received $328.3K in salary and $13.7K in other compensation.

Rankings

In 2022, David Humphrey's compensation ranked 3,550th out of 5,753 executives tracked by ExecPay. In other words, Humphrey earned more than 38.3% of executives.

ClassificationRankingPercentile
All
3,550
out of 5,753
38th
Division
Manufacturing
2,017
out of 3,133
36th
Major group
Chemicals And Allied Products
963
out of 1,419
32nd
Industry group
Drugs
901
out of 1,320
32nd
Industry
Pharmaceutical Preparations
656
out of 966
32nd
Source: SEC filing on July 13, 2023.

Humphrey's colleagues

We found three more compensation records of executives who worked with David Humphrey at Ensysce Biosciences in 2022.

2022

Dave Humphrey

Ensysce Biosciences

Chief Financial Officer

2022

Lynn Kirkpatrick

Ensysce Biosciences

Chief Executive Officer

2022

Geoff Birkett

Ensysce Biosciences

Chief Commercial Officer

News

In-depth

You may also like